comparemela.com

Latest Breaking News On - Lumicks - Page 6 : comparemela.com

New Nature Paper Relies on LUMICKS C-Trap Technology to Understand Functionality of Key Protein Involved with Incorrect DNA Repair of Dangerous Lesions Linked to Cancer Predisposition

AMSTERDAM, Feb. 15, 2022 /PRNewswire/ LUMICKS, a leading life science tools company that develops equipment for dynamic single-molecule and cell avidity analysis, today announced that its

New yorkUnited statesCity ofUnited kingdomNoord hollandSimonj boultonSloan ketteringAndrea candelliKassandra barbetseaSimon powellDavid ruedaImperial college londonLondon institute of medical sciencesFrancis crick instituteMemorial sloan ketteringWeill cornell medical

New study published in Translational Medicine highlights cell avidity s power as a functional biomarker for improved CAR-T design in preventing tumor escape

/PRNewswire/ LUMICKS, a next generation life science tools company, today announced that research findings from a consortium, led by researchers at Cancer.

Noord hollandJoshua youngMaria themeliAndrea candelliKassandra barbetseaAmsterdam university medical centersCancer center amsterdamScience translational medicineCell avidity analyzerScience translationalMovi analyzerChief scientific officerDynamic single moleculeCell avidityOptical tweezersLabel free microscopy

New study published in Translational Medicine highlights cell avidity s power as a functional biomarker for improved CAR-T design in preventing tumor escape

/PRNewswire/ LUMICKS, a next generation life science tools company, today announced that research findings from a consortium, led by researchers at Cancer.

Noord hollandJoshua youngMaria themeliAndrea candelliKassandra barbetseaAmsterdam university medical centersCancer center amsterdamScience translational medicineCell avidity analyzerScience translationalMovi analyzerChief scientific officerDynamic single moleculeCell avidityOptical tweezersLabel free microscopy

LUMICKS: New study published in Translational Medicine highlights cell avidity s power as a functional biomarker for improved CAR-T design in preventing tumor escape

AMSTERDAM, Jan. 25, 2022 /PRNewswire/ LUMICKS, a next generation life science tools company, today announced that research findings from a consortium, led by researchers at Cancer Center

Noord hollandKostenloser wertpapierhandelJoshua youngMaria themeliAndrea candelliKassandra barbetseaAmsterdam university medical centersCancer center amsterdamScience translational medicineAvidity analyzerScience translationalMovi analyzerChief scientific officerDynamic single moleculeCell avidityLabel free microscopy

LUMICKS Announces the Installation of its Quadruple C-Trap® Instrument at Rockefeller University to Expand Fundamental Research of DNA Processes

/PRNewswire/ LUMICKS today announced it has successfully installed a Quadruple C-Trap® Optical Tweezers – Fluorescence & Label-free Microscopy system at.

New yorkUnited statesRockefeller universityNoord hollandShixin liuJoshua youngPaul wheelerMichael odonnellKassandra barbetseaLaboratory of nanoscale biophysicsQuadruplec trapOptical tweezersLabel free microscopyMichaelo donnellNanoscale biophysicsFork activation

vimarsana © 2020. All Rights Reserved.